Crinetics Pharmaceuticals CRNX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Crinetics Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's free cash flow margin?
- Crinetics Pharmaceuticals (CRNX) reported free cash flow margin of -2,321.7% in Q1 2026.
- How has Crinetics Pharmaceuticals's free cash flow margin changed year-over-year?
- Crinetics Pharmaceuticals's free cash flow margin increased by 93.5% year-over-year, from -35,465.9% to -2,321.7%.
- What is the long-term trend for Crinetics Pharmaceuticals's free cash flow margin?
- Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's free cash flow margin has grown at a -11.9% compound annual growth rate (CAGR), from -8,258.3% to -4,985.5%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.